This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

Brian Vastag

JAMA. 2001;286:1826-1828.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Philadelphia—As HIV/AIDS soars past the great influenza epidemic of 1918 as the deadliest plague in the last 100 years, the best hope for stanching the pandemic lies with a vaccine. While allusions to worldwide immunization campaigns call to mind the eradication of smallpox and the containment of polio, the prospects for similar success with HIV/AIDS are considerably dimmer, at least for the next decade.

With that gloomy consensus, some 1000 otherwise optimistic vaccine researchers celebrated what organizers called an "explosion of research" at the AIDS Vaccine 2001 conference, held here in September. "There is renewed optimism that an AIDS vaccine is feasible," said conference organizer Beatrice Hahn, MD, professor of microbiology at the University of Alabama School of Medicine in Birmingham.

The energetic tenor of the conference follows 5 years of steady progress in finding chinks in HIV's shifting armor. As budgets soar, the National Institutes of . . . [Full Text of this Article]